Device recalls

Intrapulmonary Percussive Ventilation, IPV 1, Product Number: S00065; Phasitron 5 Breathing Circuit with Unified Connector, Product Number:…

Percussionaire Corporation · Labeling updated warning not to use Intrapulmonary percussive ventilation (IPV) in conjunction with volatile anesthetic delivery systems because IPV may alter…

Open, ClassifiedDevice DesignZ-3319-2026
Open FDA's page for this record
Cfres ID
222001
Product res number
Z-3319-2026
Event date initiated
2026-08-18
Event date posted
2026-09-28
Recall status
Open, Classified
Res event number
99617
Product code
NHJ
Code info
Product Number/UDI-DI: S00065/00849436000679, 00849436000709; P5-UC/00849436000686 In-Line Valve Instruction Manual: P20174 Rev D
Firm FEI number
1000524541
Recalling firm
Percussionaire Corporation
Address 1
130 Mcghee Rd Ste 109 130 Mcghee Rd
Address 2
Ste 109
City
Sandpoint
State
ID
Postal code
83864-8409
Additional info contact
Benoit Ellenrieder 208-263-2549
Root cause description
Device Design
Product quantity
61,858
Product description

Intrapulmonary Percussive Ventilation, IPV 1, Product Number: S00065; Phasitron 5 Breathing Circuit with Unified Connector, Product Number: P5-UC, used with In-Line Valve Instruction Manual

Reason for recall

Labeling updated warning not to use Intrapulmonary percussive ventilation (IPV) in conjunction with volatile anesthetic delivery systems because IPV may alter controlled delivery of volatile anesthetic agents, resulting in deeper/lighter anesthetic effects that may result in hypertonia/hypotonia, tachycardia/ bradycardia, elevated intracranial pressure, awareness during anesthesia, oversedation

Action

On 8/18/2026, correction notices were emailed to customers and distributors who were informed of the following: The following warning will be added to associated Instructions for Use: Warning: Do not use IPV therapy in conjunction with volatile anesthetic delivery systems. The high-frequency percussive flow generated during IPV therapy may alter the controlled delivery of volatile anesthetic agents within the breathing circuit, resulting in unpredictable anesthetic agent concentrations that may result in serious patient harm. Note: Consult the anesthesia healthcare provider before disconnecting from the system if considering delivering IPV directly to the patient's airway. Customers were asked to do the following: 1) Print and post the new warning for applicable IPV devices throughout your facility to ensure adequate distribution of new information to users. 2) Reinforce adherence to the IPV User Guide and IPV Quick Reference Guide instructions, including ensuring communication and training primary users of IPV therapy, specifically those using it in-line with a ventilator, on the instructions and new warning. Distributors were asked to do the following: - Translate (if applicable) and send the Urgent Medical Device Field Safety Notice to affected end customers. -If the Distributor receives the signed acknowledgement letters from affected customers, please forward them and all related communication to FSCA@sentec.com. If there are any additional questions related to the updated instructions or other questions, please contact FSCA@sentec.com

Distribution pattern

Worldwide - US Nationwide distribution including in the states of CA, PA, OK, GA, TX, OH, WI, WA, NY, MO, FL, DE, LA, SC, WV, NJ, NE, KS, NC, AL, CO, VA, OR, AZ, IL, CT, ID, NH, UT, TN, MD, VT, MS, NV, DC, ME, IA, AR, HI, ND, IN, MT, NM, MN, MI, SD, MA, AK, RI and the countries of Canada, Belgium, Chile, France, Germany, Israel, Italy, Latvia, Netherlands, Norway, Oman, Philippines, Portugal, Qatar, Russia, Saudi Arabia, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, United Kingdom, Kuwait, Australia, South Africa.

Harmonized identifiers (openFDA)
Device name
Device, Positive Pressure Breathing, Intermittent
Medical specialty description
Anesthesiology
Regulation number
868.5905
Device class
2
K number
K905236, K002598, K140605, K121955, K003684, K051964, K151689, K191912, K120277, K260604, K982016, K981726, K140598, K192143, K253001, K231728, K781232, K072292, K200988, K213564, K895485, K924174, K242438, K124032, K132988, K113549
Registration number
3017373426, 2518422, 9617566, 3008700378, 3006534321, 3006240053, 3004050971, 3006087789, 3007123976, 3020562909, 3003589956, 3008145987, 3000126629, 3009987158, 2183816, 3017520736, 3021244152, 3006446479, 3010817335, 1000604079, 3016774528, 3018783526, 3029227324, 3013095415, 3010834934, 3023272766, 2951529, 3029845, 3011120183
FEI number
3017373426, 2518422, 3008700378, 3006534321, 3006240053, 3004050971, 3006087789, 3007123976, 3020562909, 3003589956, 3008145987, 1000524541, 3000126629, 1000307109, 3009987158, 2183816, 3017520736, 3021244152, 3006446479, 3010817335, 1000604079, 3016774528, 3018783526, 3029227324, 3013095415, 3010834934, 3023272766, 3003244771, 3011120183
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.